These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 32524650

  • 1. Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
    Wahn V, Aberer W, Aygören-Pürsün E, Bork K, Eberl W, Faßhauer M, Krüger R, Magerl M, Martinez-Saguer I, Späth P, Staubach-Renz P, Weber-Chrysochoou C.
    Pediatr Allergy Immunol; 2020 Nov; 31(8):974-989. PubMed ID: 32524650
    [Abstract] [Full Text] [Related]

  • 2. Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies.
    Wahn V, Aberer W, Eberl W, Faßhauer M, Kühne T, Kurnik K, Magerl M, Meyer-Olson D, Martinez-Saguer I, Späth P, Staubach-Renz P, Kreuz W.
    Eur J Pediatr; 2012 Sep; 171(9):1339-48. PubMed ID: 22543566
    [Abstract] [Full Text] [Related]

  • 3. Interventions for the long-term prevention of hereditary angioedema attacks.
    Beard N, Frese M, Smertina E, Mere P, Katelaris C, Mills K.
    Cochrane Database Syst Rev; 2022 Nov 03; 11(11):CD013403. PubMed ID: 36326435
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G, Craig T.
    Expert Rev Clin Immunol; 2015 Mar 03; 11(3):319-27. PubMed ID: 25669442
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Hereditary Angioedema.
    Caballero T.
    J Investig Allergol Clin Immunol; 2021 Feb 03; 31(1):1-16. PubMed ID: 33602658
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A, Caccia S, Cicardi M.
    Expert Rev Clin Immunol; 2018 Sep 03; 14(9):707-718. PubMed ID: 30021471
    [Abstract] [Full Text] [Related]

  • 7. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J, Neeno T.
    Postgrad Med; 2021 Aug 03; 133(6):639-650. PubMed ID: 33993830
    [Abstract] [Full Text] [Related]

  • 8. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M.
    Expert Opin Drug Saf; 2015 Aug 03; 14(11):1725-36. PubMed ID: 26429506
    [Abstract] [Full Text] [Related]

  • 9. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K.
    Curr Opin Allergy Clin Immunol; 2014 Aug 03; 14(4):354-62. PubMed ID: 24983294
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M.
    Clin Drug Investig; 2015 Jul 03; 35(7):407-17. PubMed ID: 26091744
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R, Kuklínek P, Krčmová I, Králíčková P, Freiberger T, Janků P, Vlková M, Litzman J.
    J Clin Immunol; 2018 Oct 03; 38(7):810-815. PubMed ID: 30280305
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A, Grivcheva-Panovska V, Kessel A, Kivity S, Klimaszewska-Rembiasz M, Moldovan D, Farkas H, Gutova V, Fritz S, Relan A, Giannetti B, Magerl M.
    Pediatr Allergy Immunol; 2019 Aug 03; 30(5):562-568. PubMed ID: 30993784
    [Abstract] [Full Text] [Related]

  • 13. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
    Bork K.
    Clin Rev Allergy Immunol; 2016 Oct 03; 51(2):183-92. PubMed ID: 27207174
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.
    Cancian M, Italian network for C1-INH-HAE (ITACA).
    Curr Opin Allergy Clin Immunol; 2015 Aug 03; 15(4):383-91. PubMed ID: 26106828
    [Abstract] [Full Text] [Related]

  • 15. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M.
    Clin Ther; 2012 Mar 03; 34(3):623-30. PubMed ID: 22386830
    [Abstract] [Full Text] [Related]

  • 16. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
    Farkas H, Kőhalmi KV, Visy B, Veszeli N, Varga L.
    J Allergy Clin Immunol Pract; 2020 Mar 03; 8(7):2379-2383. PubMed ID: 32198128
    [Abstract] [Full Text] [Related]

  • 17. Hereditary and acquired angioedema.
    Patel G, Pongracic JA.
    Allergy Asthma Proc; 2019 Nov 01; 40(6):441-445. PubMed ID: 31690390
    [Abstract] [Full Text] [Related]

  • 18. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries.
    Guo Y, Zhang H, Lai H, Wang H, Chong-Neto HJ, Valle SOR, Zhu R.
    Orphanet J Rare Dis; 2022 Nov 02; 17(1):399. PubMed ID: 36324138
    [Abstract] [Full Text] [Related]

  • 19. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
    Wu MA, Zanichelli A, Mansi M, Cicardi M.
    Expert Opin Pharmacother; 2016 Nov 02; 17(1):27-40. PubMed ID: 26512744
    [Abstract] [Full Text] [Related]

  • 20. HEREDITARY ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY IN PEDIATRIC PATIENTS IN CROATIA - FIRST NATIONAL STUDY, DIAGNOSTIC AND PROPHYLACTIC CHALLENGES.
    Karadža-Lapić L, Barešić M, Vrsalović R, Ivković-Jureković I, Sršen S, Prkačin I, Rijavec M, Cikojević D.
    Acta Clin Croat; 2019 Mar 02; 58(1):139-146. PubMed ID: 31363336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.